Skip to main content
Epidemiology and Infection logoLink to Epidemiology and Infection
. 1999 Dec;123(3):373–382. doi: 10.1017/s0950268899003143

Outbreak of meningococcal disease in western Norway due to a new serogroup C variant of the ET-5 clone: effect of vaccination and selective carriage eradication.

I Smith 1, A K Lehmann 1, L Lie 1, A Digranes 1, D A Caugant 1, E A Høiby 1, L O Frøholm 1, A Halstensen 1
PMCID: PMC2810770  PMID: 10694147

Abstract

A new sulphonamide resistant (SR) C: 15:P1.7,16 meningococcal strain, a variant of the ET-5 clone, dominated in an outbreak of 22 cases in western Norway commencing in 1995. The first eight patients were 15-21 years old from the Nordhordland area, initiating a carrier study in the local high schools. Carriage of SR serogroup C meningococci was detected by routine methods and treated with a single dose of ofloxacin 400 mg. Of 20 treated carriers, 14 harboured the outbreak strain C: 15:P1.7,16. Vaccination of 4000 children, adolescents and close contacts of patients was also performed. After the intervention, 14 additional cases of meningococcal disease occurred, 8 due to the outbreak strain. However, incidence rates dropped from 180 to 30 per 100000 per year in the student population, but increased from 0 to 13 in the rest of the population in Nordhordland. Carriage eradication is not generally recommended in Norway. However, tracing and treating meningococcal carriage may have reduced transmission and disease in this outbreak situation.

Full Text

The Full Text of this article is available as a PDF (326.4 KB).


Articles from Epidemiology and Infection are provided here courtesy of Cambridge University Press

RESOURCES